作者
George S. Stergiou,Alberto Avolio,Paolo Palatini,Konstantinos G Kyriakoulis,Aletta E. Schutte,Stephan Mieke,Αναστάσιος Κόλλιας,Gianfranco Parati,Roland Asmar,Nikos Pantazis,Achilleas Stamoulopoulos,Kei Asayama,Paolo Castiglioni,Alejandro de la Sierra,Jin-Oh Hahn,Kazuomi Kario,Richard J McManus,Martin G. Myers,Takayoshi Ohkubo,Sanjeev G. Shroff,Isabella Tan,Ji‐Guang Wang,Yuan-Ting Zhang,Reinhold Kreutz,Eoin O’Brien,Ramakrishna Mukkamala
摘要
Background: There is intense effort to develop cuffless blood pressure (BP) measuring devices, and several are already on the market claiming that they provide accurate measurements. These devices are heterogeneous in measurement principle, intended use, functions, and calibration, and have special accuracy issues requiring different validation than classic cuff BP monitors. To date, there are no generally accepted protocols for their validation to ensure adequate accuracy for clinical use. Objective: This statement by the European Society of Hypertension (ESH) Working Group on BP Monitoring and Cardiovascular Variability recommends procedures for validating intermittent cuffless BP devices (providing measurements every >30 sec and usually 30–60 min, or upon user initiation), which are most common. Validation procedures: Six validation tests are defined for evaluating different aspects of intermittent cuffless devices: static test (absolute BP accuracy); device position test (hydrostatic pressure effect robustness); treatment test (BP decrease accuracy); awake/asleep test (BP change accuracy); exercise test (BP increase accuracy); and recalibration test (cuff calibration stability over time). Not all these tests are required for a given device. The necessary tests depend on whether the device requires individual user calibration, measures automatically or manually, and takes measurements in more than one position. Conclusion: The validation of cuffless BP devices is complex and needs to be tailored according to their functions and calibration. These ESH recommendations present specific, clinically meaningful, and pragmatic validation procedures for different types of intermittent cuffless devices to ensure that only accurate devices will be used in the evaluation and management of hypertension.